期刊
NEUROPHARMACOLOGY
卷 109, 期 -, 页码 159-169出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2016.06.009
关键词
Neuroinflammation; PPAR-gamma; Anti-inflammatory M2 phenotype; Microglia; Astrocytes
资金
- National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2008-0062282, 2015R1A2A1A10051958]
- Korean Health Technology R&D Project, Korean Ministry of Health Welfare [HI14C3331]
- Korean Ministry of Education, Science and Technology (MEST) [2013R1A1A261607]
- Creative Research Initiative Grant [2014R1A3A2030423]
- Bio & Medical Technology Development Program through the National Research Foundation of Korea (NRF) - Korean Government (Ministry of Science, ICT & Future Planning) [2012M3A9C4048780]
- BK21 Plus Program
Neuroinflammation is a key process for many neurodegenerative diseases. Activated microglia and astrocytes play an essential role in neuroinflammation by producing nitric oxide (NO), inflammatory cytokines, chemokines, and neurotoxins. Therefore, targeting glia-mediated neuroinflammation using small-molecules is a potential therapeutic strategy. In this study, we performed a phenotypic screen using microglia cell-based assay to identify a hit compound containing N-carbamoylated urethane moiety (SNU-BP), which inhibits lipopolysaccharide (LPS)-induced NO production in microglia. SNU-BP inhibited pro-inflammatory cytokines and inducible nitric oxide synthase in LPS-stimulated microglia, and potentiated interleukin-4-induced arginase-1 expression. PPAR-gamma was identified as a molecular target of SNU-BP. The PPAR response element reporter assay revealed that SNU-BP specifically activated PPAR-gamma, but not PPAR-delta or -alpha, confirming that PPAR-gamma is the target protein of SNU-BP. The anti-inflammatory effect of SNU-BP was attenuated by genetic and pharmacological inhibition of PPAR-gamma. In addition, SNU-BP induced an anti-inflammatory phenotype in astrocytes as well, by inhibiting pro inflammatory NO and TNF-alpha, while increasing anti-inflammatory genes, such as arginase-1 and Ym-L. Finally, SNU-BP exhibited an anti-inflammatory effect in the LPS-injected mouse brain, demonstrating a protective potential for neuroinflammatory diseases. (C) 2016 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据